XML 28 R13.htm IDEA: XBRL DOCUMENT v3.8.0.1
SEGMENT INFORMATION
3 Months Ended
Mar. 31, 2018
SEGMENT INFORMATION [Abstract]  
SEGMENT INFORMATION
6. SEGMENT INFORMATION

The Company's operating segments are based on geographic regions that generate revenue and hold its long-lived assets. The Company sells and distributes its products through a global network of customers and sales leaders in approximately 50 markets. The Company has divided these markets into seven operating segments, which are the Company's reportable segments: Mainland China, Hong Kong/Taiwan, South Korea, Japan, Southeast Asia, Americas/Pacific and EMEA. The reportable segments generate revenue from the sale of personal care products and nutritional supplements under the Nu Skin and Pharmanex brands, have similar business characteristics and align with how the CODM function began assessing performance and allocating resources in the first quarter of 2017. The Other category includes the manufacturing and product-packaging companies that the Company acquired during the first quarter of 2018, as well as the Company's indoor growing technology initiative.

Segment information for Q1 2017 has been recast to reflect the move of the Pacific components from the "South Asia/Pacific" operating segment to the "Americas/Pacific" operating segment. Consolidated financial information is not affected.
 
Profitability by segment as reported under US GAAP is driven primarily by the Company's transfer pricing policies. Segment contribution, which is the Company's segment profitability metric presented in the table below, excludes certain intercompany charges, specifically royalties, license fees, transfer pricing, discrete charges and other miscellaneous items. These charges have been included in Corporate and other expenses. Corporate and other expenses also include costs related to the Company's executive and administrative offices, information technology, research and development, marketing and supply chain functions not recorded at the segment level.

The accounting policies of the segments are the same as those described in Note 1 – The Company. The Company evaluates the performance of its segments based on revenue and segment contribution. Each segment records direct expenses related to its employees and its operations.

Summarized financial information for the Company's reportable segments is shown in the following tables. Asset information is not reviewed or included with the Company's internal management reporting. Therefore, the Company has not disclosed asset information for each reportable segment.

Revenue by Segment

  
Three Months Ended
March 31,
 
(U.S. dollars in thousands)
 
2018
  
2017
 
       
Mainland China 
 
$
197,531
  
$
150,004
 
Americas/Pacific 
  
92,289
   
71,425
 
South Korea 
  
88,930
   
82,471
 
Southeast Asia 
  
70,860
   
63,025
 
Japan 
  
63,224
   
61,156
 
EMEA 
  
44,981
   
34,064
 
Hong Kong/Taiwan 
  
40,992
   
35,948
 
Other 
  
17,412
   
1,006
 
     Total 
 
$
616,219
  
$
499,099
 

Segment Contribution

  
Three Months Ended
March 31,
 
(U.S. dollars in thousands)
 
2018
  
2017
 
       
Mainland China 
 
$
44,817
  
$
35,427
 
Americas/Pacific 
  
9,172
   
11,059
 
South Korea 
  
26,201
   
24,512
 
Southeast Asia 
  
16,402
   
13,017
 
Japan 
  
13,238
   
12,426
 
EMEA 
  
4,754
   
1,791
 
Hong Kong/Taiwan 
  
7,846
   
5,083
 
Total segment contribution 
  
122,430
   
103,315
 
Corporate and other 
  
(63,440
)
  
(57,053
)
Operating income 
  
58,990
   
46,262
 
Other income (expense) 
  
1,207
   
(4,567
)
Income before provision for income taxes
 
$
60,197
  
$
41,695
 

Depreciation and Amortization
  
Three Months Ended
March 31,
 
(U.S. dollars in thousands)
 
2018
  
2017
 
       
Mainland China 
 
$
3,487
  
$
3,971
 
Americas/Pacific 
  
214
   
566
 
South Korea 
  
1,667
   
1,632
 
Southeast Asia 
  
559
   
527
 
Japan 
  
915
   
880
 
EMEA 
  
176
   
272
 
Hong Kong/Taiwan 
  
323
   
302
 
Other 
  
11,566
   
9,475
 
      Total 
 
$
18,907
  
$
17,625
 

Capital Expenditures

  
Three Months Ended
March 31,
 
(U.S. dollars in thousands)
 
2018
  
2017
 
       
Mainland China 
 
$
1,869
  
$
903
 
Americas/Pacific 
  
189
   
234
 
South Korea 
  
   
448
 
Southeast Asia 
  
51
   
200
 
Japan 
  
311
   
76
 
EMEA 
  
35
   
193
 
Hong Kong/Taiwan 
  
482
   
606
 
Other 
  
9,715
   
13,268
 
      Total 
 
$
12,652
  
$
15,928
 

Revenue by Major Market

A major market is defined as one with total revenue greater than 10% of consolidated total revenue.  Based on this criteria, the Company has identified three major markets: Mainland China, South Korea and Japan. There are approximately 50 other markets, each of which individually is less than 10%. No single customer accounted for 10% or more of net sales for the periods presented.  Sales are recorded in the jurisdiction in which the transactions occurred.

Revenue by Product Line

  
Three Months Ended
March 31,
 
(U.S. dollars in thousands)
 
2018
  
2017
 
       
Nu Skin 
 
$
386,450
  
$
301,873
 
Pharmanex 
  
212,899
   
196,103
 
Other 
  
16,870
   
1,123
 
      Total 
 
$
616,219
  
$
499,099
 
 
Long-Lived Assets by Major Market

A major market is defined as a market with long-lived assets greater than 10% of consolidated long-lived assets and also includes the Company's country of domicile (the U.S.). Long-lived assets in Mainland China consist primarily of property, plant and equipment related to manufacturing, distribution facilities and the Mainland China headquarters. Long-lived assets in the U.S. consist primarily of property, plant and equipment, including the Company's corporate offices and distribution facilities. Long-lived assets by major markets are set forth below for the periods ended March 31, 2018 and December 31, 2017 (U.S. dollars in thousands):

  
March 31,
2018
  
December 31,
2017
 
       
United States 
 
$
348,173
  
$
302,884
 
Mainland China 
  
96,914
   
97,046
 
South Korea 
  
40,804
   
42,211
 
Japan 
  
9,305
   
9,342
 
All others 
  
13,280
   
13,104
 
      Total 
 
$
508,476
  
$
464,587